Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer.
about
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma.Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.A Phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma.Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).Triplet cytotoxic chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced pancreatic cancerChemotherapy in patients with hepatobiliary cancers and abnormal hepatic functionFabrication of gold nanoparticles for targeted therapy in pancreatic cancer.New directions in systemic therapy of pancreatic cancer.Pancreatic cancer: the evolving role of systemic therapy.Gemcitabine in combination with 5-fluorouracil with or without folinic acid in the treatment of pancreatic cancer.Antimetabolite incorporation into DNA: structural and thermodynamic basis for anticancer activity.Recent developments in the pharmacological treatment of advanced pancreatic cancer.A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancerGemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC).A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinoma.Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: a multicenter phase II study.A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid.A phase II irinotecan-cisplatin combination in advanced pancreatic cancer.A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.Gemcitabine in the treatment of metastatic pancreatic cancer.Synthesis and in vitro evaluation of novel acyclic and cyclic nucleoside analogs with a thiadiazole ringA Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.
P2860
Q30438645-11DD41A4-48A0-4E28-99AF-60F7B31A8AF1Q33338535-CDEE4780-9302-4697-B27E-DDF83B7E941EQ33340185-D9E961F4-470C-4656-BF24-13DB0781129BQ33366682-3C72C898-9139-4B80-8661-159D089BB82EQ33368148-7836599E-C00E-4F0B-BF46-D258F9A5BF4FQ33369276-598FBF61-B273-4347-8F32-0203BF53D965Q33371306-2DF7B71B-7098-4584-AF56-F3B639CFDFB6Q33389637-1D580A73-8756-4CE0-8D1C-E1C5B94C3FF1Q33428016-41480B3E-7A5E-4462-B3F8-40E418A4D422Q33593207-99B1269C-F5D2-44E1-BC4B-BC65E932F173Q33684453-D4415220-9294-4CB5-B23F-DC3F22CC3353Q34042060-A4444A4C-4EE1-4E5C-9AFD-1571F6E8F7FCQ34515547-5AECB9D9-A890-4E3B-A159-A30A023AE7F9Q34810745-1771F4A3-9B0E-4CDA-8507-FE5AA593E423Q34850202-512DC56D-A327-43CF-AEF3-983112795EC0Q35144004-823B715C-FA0D-469E-A1B0-8F950247D124Q36612255-0B54D5B9-A9F7-4048-A657-22153868F95FQ36615091-93A83CBD-3360-4EAC-943D-9AA02A01B515Q36616946-57D76C45-C24E-495D-BEA8-DFD968BCED4CQ36646040-B684935B-F348-4E32-BDDB-861F114C710DQ36670901-D4E85C71-ADAE-4A3E-BDAD-6BA13D2F461CQ36671589-BC7F97A6-F2AB-4048-A683-1BE95E78C923Q36695083-081F0FEB-3916-44C6-A1AF-381895A0378BQ37134412-51DE93B1-E6AE-4491-A186-529925ECB3EFQ42592173-09D664DE-96A5-4AB8-805E-25B55C887B64Q43869761-4684CEC3-64F8-42F8-8A7A-75808D8122B6
P2860
Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Phase I-II study of gemcitabin ...... tients with pancreatic cancer.
@ast
Phase I-II study of gemcitabin ...... tients with pancreatic cancer.
@en
Phase I-II study of gemcitabin ...... tients with pancreatic cancer.
@nl
type
label
Phase I-II study of gemcitabin ...... tients with pancreatic cancer.
@ast
Phase I-II study of gemcitabin ...... tients with pancreatic cancer.
@en
Phase I-II study of gemcitabin ...... tients with pancreatic cancer.
@nl
prefLabel
Phase I-II study of gemcitabin ...... tients with pancreatic cancer.
@ast
Phase I-II study of gemcitabin ...... tients with pancreatic cancer.
@en
Phase I-II study of gemcitabin ...... tients with pancreatic cancer.
@nl
P2093
P1476
Phase I-II study of gemcitabin ...... tients with pancreatic cancer.
@en
P2093
C Gravalos
D Castellano
H Cortes-Funes
L Paz-Ares
M Diaz-Puente
P304
P356
10.1200/JCO.1999.17.2.585
P407
P577
1999-02-01T00:00:00Z